F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to ensure that expired medications are
removed from use.
Residents Affected - Few
This applies to 1 of 5 residents (R55) reviewed for insulin storage, labeling, and administration in a sample
of 22.
The findings include:
On 3/1/23 at 11:45 AM, two medication carts were reviewed with V3, LPN (Licensed Practical Nurse).
During review, R55's Novolog insulin vial was found with open date of 1/28/23. V3, LPN, said R55's Novolog
is expired, and threw the vial in the sharps container. V3, LPN, said Novolog insulin vials expire 28 days
after opening. R55's Novolog insulin vial expiration date was 2/25/23.
On 3/2/23 at 10:45 AM, V3 said R55 only has one Novolog insulin vial stocked in the medication cart for
use at a time. V3 said the expired Novolog insulin vial that she threw in the sharps container on 3/1/23 at
11:45 AM was the same vial used since open date 1/28/23 to administer Novolog insulin to R55.
On 3/1/23 and 3/2/23 V2, ADON (Assistant Director of Nursing), and V4, LPN, said expired insulin is not as
effective in lowering elevated blood sugar levels. V2, ADON, said administering expired insulin is a
medication error.
R55's face sheet shows an admission date of 9/23/2020, and diagnosis of type 2 diabetes mellitus with
diabetic neuropathy.
R55's POS (Physician Order Sheet), shows R55 receives 7 units of Novolog three times a day and sliding
scale (1-4 units) Novolog three times a day, depending on R55's blood sugar result, related to type 2
diabetes.
R55's care plan dated 2/6/23 shows R55 is at risk for fluctuating blood sugars due to diabetes and
interventions include to administer medications as ordered.
R55's MAR (Medication Administration Record) shows from 2/26/23 through 3/1/23 at 11:45 AM, R55
received expired Novolog insulin 19 times. R55's vitals summary shows over the course of those three and
a half days, R55's blood sugar was elevated 250 or above 4 times.
Novolog insulin aspart injection 100units/mL manufacturer guidelines provided by V1, Administrator, reads
an in-use/opened multiple dose vial of Novolog has a total in-use time of 28 days.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 9
Event ID:
145737
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Manufacturer instructions say to throw away all opened Novolog vials after 28 days, even if they still have
insulin left in them.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 2 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0688
Level of Harm - Minimal harm
or potential for actual harm
Provide appropriate care for a resident to maintain and/or improve range of motion (ROM), limited ROM
and/or mobility, unless a decline is for a medical reason.
Based on observation, interview, and record review, the facility failed to apply splint/rolled towel and heel
protectors to prevent further decrease in range of motion.
Residents Affected - Few
This applies to 2 of 2 residents (R11 and R19) reviewed for range of motion in a sample of 22.
The findings include:
1. On 02/28/23 at 11:03 AM, R11 was observed not wearing a hand splint, and did not have a rolled towel
on left hand. R11's left hand was in a bent position and R11 was not able to open left hand.
On 03/01/23 at 09:42 AM, R11 was observed with no hand splint and no rolled towel on left hand.
On 03/02/23 10:59 AM, skin check done with V11 (Restorative Nurse). R11 was not wearing any splint or
rolled towel on left hand.
On 03/02/23 at 09:46 AM, interview with V11 (Restorative Nurse) stated R11 should have hand splint/
rolled towel on left hand. V11 stated R11 is on Restorative Program for splints. V11 stated R11's
splints/rolled towel should be applied in the morning and taken off at bedtime.
R11's Care Plan, dated 2/14/2023, shows he is on splint program with goal to be able to tolerate use of
splints. May use rolled towel on days that R11 refuses to wear splint.
2. On 02/28/23 at 10:48 AM, R19 observed with right foot rotated towards the center of his body. R19 was
not able to bring right foot to a neutral position. R19 was not wearing boots.
On 03/01/23 at 09:45 AM, R19 had no heel boots on, and his right foot was rotated towards the center of
his body.
R19's Restorative Assessment, dated 11/9/2022, shows R19 with limited range of motion to left and right
ankle and wears inflatable boots.
On 03/02/23 at 09:46 AM, V11 (wound nurse) stated R11 should have hand splint or rolled towel on left
hand. V11 stated restorative aides put the hand splints on but CNAs (Certified Nursing Assistant) are also
educated on how to apply them. V11 stated all floor staff is responsible in verifying that splints, braces,
rolled towel and boots are in place and kept in place. V11 stated R19 should always have boots on while he
is in bed. V11 stated R19 is always in bed.
On 03/02/23 at 12:01 PM, V2 (ADON-Assistant Director of Nursing) stated splints are applied by restorative
CNAs and they are expected to communicate with floor staff that splints have been applied. Nurses, CNAs,
and restorative aides are responsible to check and verify for splints, braces, rolled towel and heel
protectors. V2 (ADON) stated splints, braces, rolled towels are used to improve functional capabilities and if
not applied, can lead to contracture, worsening of contracture or deterioration of function.
The facility's Restorative Nursing policy (revised 7/28/2022) showed .2. Appropriate nursing and restorative
services consistent to the resident's functional needs must be provided. 3. Nursing and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 3 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0688
Restorative services may include .c. Contracture Prevention and Management . ii. Splint/Orthotic
Management.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 4 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0694
Provide for the safe, appropriate administration of IV fluids for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. R289 was
admitted to the facility on [DATE] and is cognitively intact. Diagnoses includes, but is not limited to, cellulitis
of the right lower limb, pseudomonas, lymphedema, and chronic lymphatic leukemia.
Residents Affected - Few
On 2/28/23 at 12:11 PM, R289 was noted with a PICC (Peripherally Inserted Central Catheter), dated
2/23/23, to his left upper arm. The dressing covering the PICC was soiled and lifted at the lower corners.
On 3/1/23 at 2:15 PM, R289 was noted with the same soiled PICC dressing dated 2/23/23. The bottom
edge of the PICC dressing had lifted off. R289 stated they don't do anything with his PICC.
On 3/2/23 at 10:12 AM, V13, RN (Registered Nurse), stated she had not checked his PICC. The PICC
dressing is changed by the night shift nurse on Wednesdays and as needed.
On 3/3/23 at 9:43 AM, V15, NP (Nurse Practitioner), stated, PICC line dressings are changed weekly and
as needed. If the dressing becomes dirty or the (occlusive dressing) is lifted the dressing should be
changed. If it is dirty or no longer intact it sets up a risk for infection. The line can become compromised and
impact the stability of the line causing it to be inadvertently pulled out if not secured. A line dressing left in
place past the change date also poses an increased risk for infection.
Physician order, dated 2/17/23, documents, change IV catheter dressing and cap with transparent dressing
as needed and every night shift every Wednesday. Check site for signs and symptoms of infiltration,
infection, drainage, irritation, and redness during infusion every shift.
Facility policy Intravenous Therapy, revised date 7/28/22, states, It is the facility's policy to ensure that
intravenous policy and procedure are compliant to federal standards of care. All central line dressing will be
changed every 7 days and prn (as needed).
Based on observation, interview, and record review, the facility failed to monitor and maintain PICC
(Peripherally Inserted Central Catheter) line dressings that were dirty and not occlusive.
This applies to 2 of 2 (R79, R289) residents reviewed for PICC lines in a total sample of 22.
Findings include:
1. R79's face sheet documents diagnoses including compression fracture of the lumbar vertebra, sepsis,
and osteomyelitis of vertebra.
R79's MDS (Minimum Data Set), dated 2/2/2023, showed R79 was cognitively intact. R79 requires
extensive assistance from staff for bed mobility, transfers, dressing, toileting, and personal hygiene.
On 2/28/2023 at 9:57 AM, R79's PICC line dressing was not occlusive on R79's skin. R79's dressing was
lifting 1 inch on the bottom right corner, and the tubing was observed to be exposed to air. R79's PICC line
did not have a disinfection cap at the end of the needless connector. R79 said the PICC line dressing was
last changed two weeks ago. On 3/2/2023 at 1:04 PM, R79 said, They've [staff] all seen it. Even (V12,
LPN/Licensed Practical Nurse) asked me why they hadn't changed it when they saw
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 5 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0694
it coming off.
Level of Harm - Minimal harm
or potential for actual harm
Multiple observations were made from 2/28/2023 through 3/2/2023 of R79's PICC line, and no disinfection
cap was placed on the needless connector.
Residents Affected - Few
On 3/1/2023 at 11:04 AM, V2 (Assistant Director of Nursing/Interim Director of Nursing) observed R79's
PICC line, and told R79 his PICC should have a disinfection cap on the end of the needless connector. On
3/1/2023 at 2:03 PM, V2 also said the PICC line dressing should be changed weekly and as needed. V2
said the dressing should be changed and stabilized if the dressing is lifting, saturated, skin irritation, and
there are changes around the skin, as there is risk for movement and breaking of the catheter. V2 also said
there should be a disinfection cap at the end of the PICC line to prevent infection.
Record review of R79's TAR (Treatment Administration Record) documents the dressing was last changed
on 2/15/2023. The TAR shows the dressing was due to be changed on 2/22/2023, but no treatment
administration was documented. R79's progress notes were reviewed from 2/10/2023 to present, and no
documentation of dressing change of the PICC line was found. R79's MAR (Medication Administration
Record) shows R79 receives medication through the PICC line every eight hours.
The facility's Intravenous Therapy policy, reviewed on 7/28/2022, documents It is the facility's policy to
ensure that intravenous policy and procedure are compliant to federal standard of care and All central line
dressing will be changed every 7 days and prn (As Needed).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 6 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to follow physician orders for pain management and
assessment. This applies to 1 of 3 residents (386) reviewed for pain management in a sample of 22.
Residents Affected - Few
Finding includes:
On 11/22/2022 at 11:08 AM, R386 indicated he wanted to take his Tylenol #3 medication for pain for three
days since the admission to the facility on [DATE], and he has been asking staff, with no help. R386 said he
has been taking Tylenol #3 for 30 years for his chronic pain. R386 said he was recently admitted to the
hospital with severe abdominal pain before coming to the facility and received Tylenol #3 at the hospital
also. R1 said he feels he has a 10 out of 10 pain rating (10 indicates highest pain) most of the time in his
shoulder, back, and sometimes in his legs due to spinal stenosis of the back, kidney injury, and gallbladder
stone-related conditions.
On 03/01/2023 at 11:19 AM, R386 said he asked for Tylenol #3 at night and in the morning around 7:30
AM, and still didn't get it. R386 further said he also reported to V8 (Occupational Therapy Aide) and
V9(Physical Therapy Aide) on 02/28/2023.
On 03/02/2023, V7 (Certified Nursing Assistant) at 2:00 PM, and V9 (Physical Therapy Aide) at 11:45 AM,
said R386 reported shoulder pain to them on 02/27/2023, and they reported it to the nurse for R386. V9
said R386 reported back pain on 02/28/2023, and they reported it to the nurse on duty.
R386's admission Physician Order Sheet (POS), dated 02/25/2023, indicated R1 could have a Tylenol #3
tablet of 300-30 milligrams every 12 hours as needed for pain. A review of the narcotic binder sign out
sheets on 02/28/2023 at 12:00 PM, indicated R386 did not have a sign out sheet for Tylenol #3.
R1's Physician's Order sheet, dated 02/25/2023, shows diagnoses included acute cholecystitis, acute
kidney injury, spinal stenosis of the lumbar region, and type 2 diabetes. R386's admission Minimum Data
Set (MDS) in progress indicated R1 was cognitively moderately intact, and the admission care plan
indicated evaluating pain and providing pain medication as ordered.
On 02/28/2023 at 11:45 AM, V5 (Nurse from Agency) said she was unaware of the physician's order, and
would call the pharmacy immediately.
On 03/02/2023 at 12:00 PM, V6 (Licensed Practical Nurse) said she called the pharmacy on 02/25/2023.
On 03/02/2023 at 12:50 PM, V10 (Pharmacy Director of Quality) said they don't have any call records of the
facility calling for Tylenol #3 on 02/25/2023. They did receive a call on 02/28/2023 for a Tylenol #3 order for
R386, and delivered the medication to the facility.
On 03/02/2023 at 12:00 PM, V6(Licensed Practical Nurse) and V2 (Assistant Director of Nursing) said
nurses should follow the physician's order, residents should be assessed for pain, and pain medication
should be administered as ordered.
A review of physician order revised policies, dated 07/28/2022, indicated in part, the facility shall ensure to
follow physician order as it's written in the POS.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 7 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to assure that medications were secured. This
applies to R49 and R289 reviewed for medication storage in a sample size of 22.
1. R289 was admitted to the facility on [DATE] per current Physician's Order Sheet, with diagnoses to
include, but is not limited to, cellulitis of the right lower limb, pseudomonas, lymphedema, and chronic
lymphatic leukemia.
On 2/28/23 at 12:11 PM, a half- filled bottle of Cefuroxime 500mg, dated 12/09/22, was on top of R289's
bedside table.
On 3/2/23 at 9:50 AM, R289 was still in possession of the bottle of Cefuroxime.
On 3/2/23 at 10:12 AM, V13, RN (Registered Nurse), stated R289 did not have an assessment to keep
medications at his bedside. Residents are not typically allowed to keep their medications at the bedside.
On 3/2/23 at 10:23 AM, V14, Nurse Consultant, stated there should not be any medications left at bedside.
If a resident was going to have medications at the bedside, they would need an assessment and physicians
order.
On 3/2/23 at 1:05 PM, V14 stated R289 did not have an assessment to keep medication at the bedside.
On 3/3/23 at 9:43 AM, V15, Nurse Practitioner, stated she had no knowledge of any resident at the facility
being assessed to keep medications at the bedside. There is a potential for the resident to take something
they shouldn't have or take much or not enough. Medications need to be listed by the pharmacy to
determine if there is a negative drug interaction. Medications should be secured because a confused
resident could wander into the room and take those medications by mistake.
Review of R289 current physician orders (March 2023) does not list Cefuroxime.
The facility policy Medication Storage, Labeling and Disposal policy, revised date 10/24/22, states federal it
is facility's policy to comply with federal regulations in storage, labeling and disposal of medications.
Medications will be stored safely under appropriate environmental controls. Medications will be secured in
locked storage area.
2. R49's face sheet documents diagnoses including cerebral infarction, attention-deficit hyperactivity
disorder, paranoid personality disorder, anxiety, obsessive compulsive disorder, depression, lupus, and
seizures.
On 2/28/2023 at 10:33 AM, R49's bedside table was observed to have (brand name) multivitamins. On
3/2/2023 at 9:51 AM, R49's bedside table was observed to have (brand name) multivitamins and irritable
bowel syndrome therapy. R49's bedside table also had a medicine cup, and R49 said the nurse gave her
the medications and she would be taking them after having food. According to R49, the medications were
Aspirin, Potassium, Vitamin D, Calcium, and Cranberry. R49 said she had already taken her own
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 8 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Terra Lagrange
4735 Willow Springs Road
LA Grange, IL 60525
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
supply of Vitamin D 5000 units, and will be throwing away the Vitamin D and another pill given to her by the
nurse. R49 opened her bedside drawer and removed additional medications including coenzyme Q10 200
mg (Milligrams), Vitamin D3 5000 units, Acetyl L carnitine 1500 mg, Bio 360 probiotics, Dr. formulated
probiotics 40 billion CFU (Colony Forming Unit), and gas relief simethicone 125 mg.
On 3/2/2023 at 1:50 PM, V3 (LPN/Licensed Practical Nurse) said R49 takes her vitamins after her meals.
V3 said she gives R49 the medications and then comes back after her meal to check if she takes them. V3
was not aware R49 had not taken all the medications given by V3. V3 said she was aware R49 had home
medications at the bedside, but was unsure of what they were and what R49 was taking. V3 said she knew
it was not appropriate for her to leave the medications in the room if the resident was not taking it, and it
was not appropriate for her to take her home supply of medications without the doctor knowing.
On 3/1/2023 at 2:03 PM, V2 (Assistant Director of Nursing/Interim Director of Nursing) said residents taking
home medications should be assessed, educated, and care planned to have medications at the bedside.
V2 said the doctor should be notified and are the ones to put an order in to have medications at the bedside
and to self-administer.
Record review of R49's POS (Physician Order Sheet) does not show an order for (brand name)
multivitamins, irritable bowel syndrome therapy, coenzyme Q10 200 mg, Acetyl L carnitine 1500 mg, Bio
360 probiotics, and Dr. formulated probiotics 40 billion CFU (Colony Forming Unit). R49's POS shows an
order for simethicone 80 mg tablet and vitamin D3 1000 units. R49 was taking simethicone 125 mg and
vitamin D3 5000 units from her home supply of medications. R49's POS does not have an order in place for
medications at the bedside and self-administration of medications. The facility was unable to provide
documentation regarding R49's self-administration of medication assessment or care plan.
The facility policy Medication Storage, Labeling and Disposal policy, revised date 10/24/22, states federal it
is facility's policy to comply with federal regulations in storage, labeling and disposal of medications.
Medications will be stored safely under appropriate environmental controls. Medications will be secured in
locked storage area.
The facility's Self-Administration of Medication policy, reviewed on 7/28/2022, documents, The IDT
[Interdisciplinary Team] will assign a staff to evaluate resident's ability to safely administer medication. A
Self-Administration Evaluation will be filled out to determine capability and the resident may store the
medication at bedside if there is a physician order to keep it at bedside and The nurse on duty will
document administration of medication in the MAR [Medication Administration Record].
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145737
If continuation sheet
Page 9 of 9